I C Abbs

719 total citations
27 papers, 511 citations indexed

About

I C Abbs is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, I C Abbs has authored 27 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 7 papers in Immunology and 6 papers in Nephrology. Recurrent topics in I C Abbs's work include Systemic Lupus Erythematosus Research (10 papers), Renal Diseases and Glomerulopathies (5 papers) and Complement system in diseases (4 papers). I C Abbs is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Renal Diseases and Glomerulopathies (5 papers) and Complement system in diseases (4 papers). I C Abbs collaborates with scholars based in United Kingdom, Canada and United States. I C Abbs's co-authors include David D’Cruz, Mohammed Yousuf Karim, María J. Cuadrado, Munther A. Khamashta, Steven H. Sacks, Francisco J. Sánchez-Gómez, Graham Hughes, Cecilia Pisoni, Rosemary L. Donne and Shirish Sangle and has published in prestigious journals such as Journal of Bone and Mineral Research, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

I C Abbs

27 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I C Abbs United Kingdom 13 181 180 139 112 86 27 511
Noosha Baqi United States 11 155 0.9× 250 1.4× 69 0.5× 40 0.4× 53 0.6× 18 433
Jane Tizard United Kingdom 12 159 0.9× 219 1.2× 111 0.8× 62 0.6× 20 0.2× 19 478
Philippe Grimbert France 11 89 0.5× 295 1.6× 60 0.4× 70 0.6× 27 0.3× 24 577
Patrizia Scaini Italy 8 152 0.8× 262 1.5× 42 0.3× 87 0.8× 100 1.2× 14 441
Shigemi Chiba Japan 9 64 0.4× 437 2.4× 72 0.5× 156 1.4× 69 0.8× 13 639
Alberto Magnasco Italy 15 99 0.5× 633 3.5× 181 1.3× 116 1.0× 15 0.2× 37 1.1k
F. Ortíz-Sanjuán Spain 13 256 1.4× 121 0.7× 44 0.3× 39 0.3× 108 1.3× 43 581
Y. Schoindre France 10 239 1.3× 71 0.4× 138 1.0× 60 0.5× 120 1.4× 25 733
Reiad Najjar United States 15 57 0.3× 168 0.9× 143 1.0× 82 0.7× 24 0.3× 26 742
Katia Stankovic Stojanovic France 17 59 0.3× 104 0.6× 183 1.3× 290 2.6× 35 0.4× 36 710

Countries citing papers authored by I C Abbs

Since Specialization
Citations

This map shows the geographic impact of I C Abbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I C Abbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I C Abbs more than expected).

Fields of papers citing papers by I C Abbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I C Abbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I C Abbs. The network helps show where I C Abbs may publish in the future.

Co-authorship network of co-authors of I C Abbs

This figure shows the co-authorship network connecting the top 25 collaborators of I C Abbs. A scholar is included among the top collaborators of I C Abbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I C Abbs. I C Abbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leach, Richard, Sandip Banerjee, Simon Steddon, et al.. (2019). Quality Improvement: Supporting a hospital in difficulty: experience of a ‘buddying’ agreement to implement a new medical pathway. Future Healthcare Journal. 6(1). 67–75. 5 indexed citations
2.
Bartlett, Mark, et al.. (2018). The power of digital communications: improving outpatient attendances in south London. Future Healthcare Journal. 5(1). 43–46. 3 indexed citations
3.
Farmer, Chris, Geeta Hampson, I C Abbs, et al.. (2006). Late Low-Dose Steroid Withdrawal in Renal Transplant Recipients Increases Bone Formation and Bone Mineral Density. American Journal of Transplantation. 6(12). 2929–2936. 27 indexed citations
4.
Karim, Mohammed Yousuf, M.F. Tungekar, I C Abbs, et al.. (2005). Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. Lara D. Veeken. 44(10). 1317–1321. 35 indexed citations
5.
Pisoni, Cecilia, Francisco J. Sánchez-Gómez, Mohammed Yousuf Karim, et al.. (2005). Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.. PubMed. 32(6). 1047–52. 77 indexed citations
6.
Elsharkawy, Ahmed M., F. Perrin, Chris Farmer, et al.. (2004). Symptomatic cytomegalovirus infection complicating treatment of acute systemic vasculitis. Clinical Nephrology. 62(10). 319–326. 1 indexed citations
7.
Bennett, Alexander N., Paul Peterson, Shirish Sangle, et al.. (2004). Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Lara D. Veeken. 43(6). 795–799. 37 indexed citations
8.
Ferro, Michela, Mohammed Yousuf Karim, I C Abbs, et al.. (2003). Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis.. Research Portal (King's College London). 48(9). 3 indexed citations
9.
Farmer, Chris, Geeta Hampson, S. Vaja, et al.. (2002). Late low dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density without altering renal function: A randomised controlled trial.. Journal of Bone and Mineral Research. 17. 1 indexed citations
10.
Donne, Rosemary L., I C Abbs, Peter Bárány, et al.. (2002). Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. American Journal of Kidney Diseases. 40(6). e22.1–e22.4. 58 indexed citations
11.
Taylor, John, et al.. (2002). Acute allograft pancreatitis associated with renal allograft rejection. Nephrology Dialysis Transplantation. 17(2). 288–290. 2 indexed citations
12.
Okpala, Iheanyi, Veronica J. Thomas, Kavita Raj, et al.. (2002). The comprehensive care of sickle cell disease. European Journal Of Haematology. 68(3). 157–162. 61 indexed citations
13.
14.
Masterson, Rosemary, Neil Sheerin, I C Abbs, & David Goldsmith. (2001). Late allograft loss due to recurrence of p‐ANCA‐associated systemic vasculitis in a patient with relapsing polychondritis. Nephrology Dialysis Transplantation. 16(8). 1705–1707. 5 indexed citations
15.
Dalton, R. Neil, et al.. (2001). Dimethylarginines in chronic renal failure. Journal of Clinical Pathology. 54(6). 470–473. 41 indexed citations
16.
Fofi, Claudia, María J. Cuadrado, Tim Godfrey, et al.. (2001). Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis.. PubMed. 19(1). 75–7. 16 indexed citations
17.
Irish, Dianne, J. Craske, Lisa Burnapp, et al.. (1999). Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: Implications for infection control and laboratory screening. Journal of Medical Virology. 59(2). 135–140. 1 indexed citations
18.
Harman, Karen, et al.. (1998). Scleromyxoedema and thrombotic thrombocytopaenic purpura: two rare conditions both responding to plasma exchange. Journal of the European Academy of Dermatology and Venereology. 11(1). 59–65. 3 indexed citations
19.
Robson, Michael G. & I C Abbs. (1997). Thrombotic thrombocytopenic purpura following hemicolectomy for colonic carcinoma. Nephrology Dialysis Transplantation. 12(1). 198–199. 16 indexed citations
20.
Abbs, I C, Julian R. Pratt, Margaret J. Dallman, & Steven H. Sacks. (1993). Analysis of activated T cell infiltrates in rat renal allografts by gamma camera imaging after injection of 123iodine-interleukin 2. Transplant Immunology. 1(1). 45–51. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noosha Baqi Breakdown of academic impact, for papers by Jane Tizard Breakdown of academic impact, for papers by Philippe Grimbert Breakdown of academic impact, for papers by Patrizia Scaini Breakdown of academic impact, for papers by Shigemi Chiba Breakdown of academic impact, for papers by Alberto Magnasco Breakdown of academic impact, for papers by F. Ortíz-Sanjuán Breakdown of academic impact, for papers by Y. Schoindre Breakdown of academic impact, for papers by Reiad Najjar Breakdown of academic impact, for papers by Katia Stankovic Stojanovic
Rankless by CCL
2026